These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6824325)

  • 1. Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test.
    Gilligan PH; Brown L; Berman RE
    Appl Environ Microbiol; 1983 Jan; 45(1):347-9. PubMed ID: 6824325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.
    Paton JC; Lawrence AJ; Manson JI
    J Clin Microbiol; 1982 Jan; 15(1):1-4. PubMed ID: 6764763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism.
    Paton JC; Lawrence AJ; Steven IM
    J Clin Microbiol; 1983 Jan; 17(1):13-5. PubMed ID: 6338033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism.
    Dezfulian M; Hatheway CL; Yolken RH; Bartlett JG
    J Clin Microbiol; 1984 Sep; 20(3):379-83. PubMed ID: 6490825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of Clostridium difficile toxin in human feces.
    Ryan RW; Kwasnik I; Tilton RC
    J Clin Microbiol; 1980 Dec; 12(6):776-9. PubMed ID: 7031079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxin A in infants.
    Libby JM; Donta ST; Wilkins TD
    J Infect Dis; 1983 Sep; 148(3):606. PubMed ID: 6619580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme immunoassay (ELISA) for detection of Clostridium difficile toxin B in specimens of faeces.
    Nguyen VK; Rihn B; Heckel C; Bisseret F; Girardot R; Monteil H
    J Med Microbiol; 1990 Apr; 31(4):251-7. PubMed ID: 2325114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory aspects of infant botulism in California.
    Midura TF
    Rev Infect Dis; 1979; 1(4):652-5. PubMed ID: 399372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Clostridium botulinum type A toxin and organisms in the feces of a case of infant botulism and examination of other related specimens.
    Takahashi M; Shimizu T; Ooi K; Noda H; Nasu T; Sakaguchi G
    Jpn J Med Sci Biol; 1988 Feb; 41(1):21-6. PubMed ID: 3057266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Bano L; Tonon E; Drigo I; Pirazzini M; Guolo A; Farina G; Agnoletti F; Montecucco C
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29921757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin.
    Popoff MR
    Infect Immun; 1987 Jan; 55(1):35-43. PubMed ID: 3793234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral botulism at dairy farms in Schleswig Holstein, Germany: prevalence of Clostridium botulinum in feces of cows, in animal feeds, in feces of the farmers, and in house dust.
    Krüger M; Große-Herrenthey A; Schrödl W; Gerlach A; Rodloff A
    Anaerobe; 2012 Apr; 18(2):221-3. PubMed ID: 22200452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory procedures for cases of suspected infant botulism.
    Hatheway CL
    Rev Infect Dis; 1979; 1(4):647-51. PubMed ID: 551514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay.
    Lewis GE; Kulinski SS; Reichard DW; Metzger JF
    Appl Environ Microbiol; 1981 Dec; 42(6):1018-22. PubMed ID: 7316509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Fecal Excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from Infant Botulism.
    Dabritz HA; Payne JR; Khouri JM
    J Pediatr; 2023 Jul; 258():113396. PubMed ID: 37004956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
    Martinez RD; Wilkins TD
    Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.